ストックスクリーナーアプリを入手
4.3504
6.15%
0.2504
前日終値:
$4.10
開ける：
$4.11
24時間の取引高:
705.60K
Relative Volume:
0.67
時価総額：
$538.87M
収益：
$69.56M
当期純損益:
$-240.05M
株価収益率:
-1.4747
EPS:
-2.95
ネットキャッシュフロー:
$-121.90M
1週間 パフォーマンス:
+9.08%
1か月 パフォーマンス:
+20.56%
6か月 パフォーマンス:
+36.86%
1年 パフォーマンス:
+167.00%
1日の値動き範囲:
$4.11
$4.41
1週間の範囲:
$3.845
$4.41
52週間の値動き範囲:
$1.05
$4.80
Adc Therapeutics Sa Stock (ADCT) Company Profile
Compare ADCT vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ADCT
Adc Therapeutics Sa
|
4.35 | 507.90M | 69.56M | -240.05M | -121.90M | -2.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
485.83 | 121.15B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
788.50 | 82.43B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
835.15 | 52.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.60 | 44.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
366.96 | 40.07B | 4.98B | 69.60M | 525.67M | 0.5198 |
Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-08 | 開始されました | Stephens | Overweight |
| 2024-05-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-03-28 | 開始されました | Guggenheim | Buy |
| 2023-08-10 | アップグレード | JP Morgan | Underweight → Neutral |
| 2023-04-24 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-12-06 | 開始されました | CapitalOne | Overweight |
| 2022-11-09 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-09-21 | 開始されました | JP Morgan | Overweight |
| 2022-09-09 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-09 | 開始されました | Wolfe Research | Outperform |
| 2021-08-17 | 再開されました | Jefferies | Buy |
| 2021-08-09 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-06-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-12-03 | 開始されました | Stifel | Hold |
| 2020-10-29 | 開始されました | H.C. Wainwright | Buy |
| 2020-06-09 | 開始されました | BofA/Merrill | Buy |
| 2020-06-09 | 開始されました | Cowen | Outperform |
すべてを表示
Adc Therapeutics Sa (ADCT) 最新ニュース
ADC Therapeutics Amends HealthCare Royalty Financing Agreement - marketscreener.com
ADC Therapeutics Amends Royalty Deal, Issues New Warrants - TipRanks
ADC Therapeutics amends royalty deal with HealthCare Royalty By Investing.com - Investing.com Canada
Stepan Co recently released a project impact forecast, estimating that the cash impact over the entire project cycle will range between $29 million and $44 million, while the non-cash impact is expected to be between $58 million and $62 million. - Bitget
ADC Therapeutics SA (ADCT) recently released its performance outlook, expecting the company to enter a substantial growth phase starting in 2027. - Bitget
Healthcare Royalty Partners granted warrants to purchase approximately 9.8 million ordinary shares to ADC Therapeutics SA. - Bitget
ADC Therapeutics SA announced that, in the event of a change of control, the acquirer will continue to pay royalties to the healthcare royalty company until the originally agreed cap amount is reached. - Bitget
ADC Therapeutics amends royalty deal with HealthCare Royalty - Investing.com
ADC Therapeutics grants warrants to Healthcare Royalty - Investing.com
ADC Therapeutics grants warrants to Healthcare Royalty By Investing.com - Investing.com UK
ADC Therapeutics Amends HCR Royalty Financing, Sets $150–$200 Million Change-of-Control Payment - TradingView
ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement - PR Newswire
Analyst Calls: Is ADC Therapeutics SA affected by consumer sentimentWeekly Trade Recap & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Aug Patterns: Is CommScope Holding Company Inc stock undervalued right nowJuly 2025 Recap & Detailed Earnings Play Strategies - baoquankhu1.vn
ADCT SEC FilingsAdc Therapeutics Sa 10-K, 10-Q, 8-K Forms - Stock Titan
Has ADC Therapeutics (ADCT) outpaced other medical stocks this year? - MSN
ADC Therapeutics Announces Investigator-Initiated Study Abstract - GuruFocus
Will ADC Therapeutics SA stock sustain high P E ratiosMarket Activity Report & Risk Controlled Swing Trade Alerts - mfd.ru
What drives ADC Therapeutics SA’s stock priceJuly 2025 Setups & Growth Focused Investment Plans - mfd.ru
Can ADC Therapeutics SA stock deliver consistent earnings growth - mfd.ru
Can ADC Therapeutics SA stock outperform in 2025 bull marketEarnings Miss & Safe Capital Growth Stock Tips - mfd.ru
Will ADC Therapeutics SA stock hit new highs in YEARQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - mfd.ru
Analysts Set ADC Therapeutics SA (NYSE:ADCT) Price Target at $7.50 - Defense World
Bond Watch: Is ADC Therapeutics SA a stock for growth or value investorsGDP Growth & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
ADC Therapeutics SA (NYSE:ADCT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.5%Here's Why - MarketBeat
ADC Therapeutics (NYSE:ADCT) Trading Down 4.5%Here's What Happened - MarketBeat
ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.5% – Here’s Why - Defense World
Little Excitement Around ADC Therapeutics SA's (NYSE:ADCT) Revenues - 富途牛牛
ADC Therapeutics SA's (NYSE:ADCT) Price Is Right But Growth Is Lacking - simplywall.st
Update On ADCs: Sales, Deals, Targets And Approvals - Citeline News & Insights
ADC Therapeutics Grants Stock Options to New Employees - Intellectia AI
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - Finviz
ADC Therapeutics (ADCT) upgraded to buy: Here's why - MSN
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan – Company Announcement - Financial Times
Growth Review: Can ADC Therapeutics SA continue delivering strong returns2025 Major Catalysts & Technical Pattern Recognition Alerts - baoquankhu1.vn
Is ADC Therapeutics SA stock a good dividend stockNew Guidance & High Accuracy Swing Entry Alerts - mfd.ru
$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium - marketscreener.com
Has ADC Therapeutics (ADCT) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Can ADC Therapeutics SA expand its profit marginsTrade Entry Report & Long-Term Growth Stock Strategies - mfd.ru
Does ADC Therapeutics SA align with a passive investing strategyJuly 2025 Institutional & Capital Efficient Trading Techniques - mfd.ru
Will ADC Therapeutics SA benefit from sector rotation2025 Market Overview & Long-Term Investment Growth Plans - mfd.ru
Moving Averages: Why is ADC Therapeutics SA stock going upStock Surge & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Risk Off: Is ADC Therapeutics SA stock showing strong momentumPortfolio Gains Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Weekly Trades: Can ADC Therapeutics SA continue delivering strong returnsLayoff News & Verified Entry Point Detection - mfd.ru
Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SAADCT - marketscreener.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SAADCT - PR Newswire
ADC Therapeutics Faces Securities Fraud Investigation, Stock Drops 14.13% - intellectia.ai
Breakouts Watch: Will ADC Therapeutics SA benefit from sector rotationWeekly Stock Report & Growth Oriented Trade Recommendations - baoquankhu1.vn
Insider Trends: Can ADC Therapeutics SA disrupt its industryQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Is ADC Therapeutics SA stock attractive for retirement portfoliosWeekly Gains Report & Real-Time Volume Surge Alerts - bollywoodhelpline.com
Adc Therapeutics Sa (ADCT) 財務データ
収益
当期純利益
現金流量
EPS
0.88%
0.77%
大文字化:
|
ボリューム (24 時間):